Measure: CMS145
Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ? 40%)
Measure Versions
| eMeasure Code |
Measure Year |
Full Version Number |
Title |
| CMS145v12 |
2024 |
12.0.000 |
Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <=40%) |
| CMS145v11 |
2023 |
11 |
Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ? 40%) |
| CMS145v10 |
2022 |
10.1.000 |
Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) |
| CMS145v9 |
2021 |
9.2.000 |
Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) |
| CMS145v8 |
2020 |
8.2.000 |
Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) |
| CMS145v7 |
2019 |
7.2.000 |
Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) |
| CMS145v6 |
2018 |
6.0.000 |
Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) |
| CMS145v5 |
2017 |
5.2.000 |
Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) |
Description
Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period who also have a prior MI or a current or prior LVEF ? 40% who were prescribed beta-blocker therapy.
Guidance
Patient Group Definitions
| Group |
Description |
Instructions Links |
| Initial Population | All patients aged 18 years and older with two qualifying encounters during the measurement period and a diagnosis of coronary artery disease | Webchart Instructions |
| Denominator | Equals Initial Population who also have prior (within the past 3 years) MI or a current or prior LVEF <=40% | Webchart Instructions |
| Denominator Exclusions | None | |
| Numerator | Patients who were prescribed beta-blocker therapy | Webchart Instructions |
| Numerator Exclusions | Not Applicable | Webchart Instructions |
| Denominator Exceptions | Documentation of medical reason(s) for not prescribing beta-blocker therapy (e.g., arrhythmia, asthma, bradycardia, hypotension, patients with atrioventricular block without cardiac pacer, observation of consecutive heart rates <50, allergy, intolerance, other medical reasons).
Documentation of patient reason(s) for not prescribing beta-blocker therapy (e.g., patient declined, other patient reasons).
Documentation of system reason(s) for not prescribing beta-blocker therapy (e.g., other reasons attributable to the health care system). | Webchart Instructions |
Details
| Full eMeasure Code |
eMeasure Identifier |
Measure Year |
Version |
NQF # |
GUID |
| CMS145v11 |
145 |
2023 |
11 |
0070 |
80744ae2-de81-4b16-a71d-69522eb865c5 |
| Steward |
Developer |
Endorsed By |
| American Heart Association |
American Medical Association (AMA) |
National Quality Forum |
| Scoring Method |
Measure Type |
Stratification |
Risk Adjustment |
| Proportion |
Process |
None |
None |
Rate Aggregation
This measure is intended to have one reporting rate, which aggregates the following populations into a single performance rate for reporting purposes:
- Population 1: Patients with left ventricular systolic dysfunction (LVEF <=40%)
- Population 2: Patients with a prior (within the past 3 years) myocardial infarction
For the purposes of this measure, a single performance rate can be calculated as follows:
Performance Rate = (Numerator 1 + Numerator 2)/ [(Denominator 1 - Denominator Exceptions 1) + (Denominator 2 - Denominator Exceptions 2)]
Improvement Notation
Higher score indicates better quality
Rationale
Clinical Recommendation Statement
Definition
Transmission Format
Applicable Value Sets
| Category |
Value Set |
OID |
| Allergy/Intolerance |
Beta Blocker Therapy Ingredient |
2.16.840.1.113883.3.526.3.1493 |
| Diagnosis |
Allergy to Beta Blocker Therapy |
2.16.840.1.113883.3.526.3.1177 |
| Diagnosis |
Arrhythmia |
2.16.840.1.113883.3.526.3.366 |
| Diagnosis |
Asthma |
2.16.840.1.113883.3.526.3.362 |
| Diagnosis |
Atrioventricular Block |
2.16.840.1.113883.3.526.3.367 |
| Diagnosis |
Bradycardia |
2.16.840.1.113883.3.526.3.412 |
| Diagnosis |
Cardiac Pacer in Situ |
2.16.840.1.113883.3.526.3.368 |
| Diagnosis |
Coronary Artery Disease No MI |
2.16.840.1.113883.3.526.3.369 |
| Diagnosis |
Hypotension |
2.16.840.1.113883.3.526.3.370 |
| Diagnosis |
Intolerance to Beta Blocker Therapy |
2.16.840.1.113883.3.526.3.1178 |
| Diagnosis |
Moderate or Severe LVSD |
2.16.840.1.113883.3.526.3.1090 |
| Diagnosis |
Myocardial Infarction |
2.16.840.1.113883.3.526.3.403 |
| Diagnostic Study, Performed |
Ejection Fraction |
2.16.840.1.113883.3.526.3.1134 |
| Encounter, Performed |
Care Services in Long-Term Residential Facility |
2.16.840.1.113883.3.464.1003.101.12.1014 |
| Encounter, Performed |
Home Healthcare Services |
2.16.840.1.113883.3.464.1003.101.12.1016 |
| Encounter, Performed |
Nursing Facility Visit |
2.16.840.1.113883.3.464.1003.101.12.1012 |
| Encounter, Performed |
Office Visit |
2.16.840.1.113883.3.464.1003.101.12.1001 |
| Encounter, Performed |
Outpatient Consultation |
2.16.840.1.113883.3.464.1003.101.12.1008 |
| Encounter, Performed |
Patient Provider Interaction |
2.16.840.1.113883.3.526.3.1012 |
| Medication, Active |
Beta Blocker Therapy |
2.16.840.1.113883.3.526.3.1174 |
| Medication, Active |
Beta Blocker Therapy for LVSD |
2.16.840.1.113883.3.526.3.1184 |
| Medication, Not Ordered |
Beta Blocker Therapy |
2.16.840.1.113883.3.526.3.1174 |
| Medication, Not Ordered |
Beta Blocker Therapy for LVSD |
2.16.840.1.113883.3.526.3.1184 |
| Medication, Order |
Beta Blocker Therapy |
2.16.840.1.113883.3.526.3.1174 |
| Medication, Order |
Beta Blocker Therapy for LVSD |
2.16.840.1.113883.3.526.3.1184 |
| Patient Characteristic Ethnicity |
Ethnicity |
2.16.840.1.114222.4.11.837 |
| Patient Characteristic Payer |
Payer |
2.16.840.1.114222.4.11.3591 |
| Patient Characteristic Race |
Race |
2.16.840.1.114222.4.11.836 |
| Patient Characteristic Sex |
ONC Administrative Sex |
2.16.840.1.113762.1.4.1 |
| Physical Exam, Performed |
Heart Rate |
2.16.840.1.113883.3.526.3.1176 |
| Procedure, Performed |
Cardiac Pacer |
2.16.840.1.113762.1.4.1178.53 |
| Procedure, Performed |
Cardiac Surgery |
2.16.840.1.113883.3.526.3.371 |
References
Disclaimer
Copyright
Source:
https://ecqi.healthit.gov/ecqm/measures/cms145v1